Home › Funds › Versant Venture Management, LLC › CRSP

Versant Venture Management, LLC position in CRSP

CRISPR THERAPEUTICS AG · Health Care

Versant Venture Management, LLC reported holding 148,831 shares of CRSP (CRISPR THERAPEUTICS AG) in its Q3 2026 13F filing — a position valued at US$8.2M, representing 7.55% of its reported portfolio and ranking #6 among its reported holdings. Versant Venture Management, LLC has disclosed CRSP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)148.83K sh
Reported value held$8.23M
Portfolio Weight7.55%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Versant Venture Management, LLC's CRSP position evolved

Versant Venture Management, LLC first disclosed a stake in CRSP in Q3 2023 at 498,558 shares (US$22.6M). The position peaked in Q1 2024 at 498,558 shares, worth US$34.0M. Across 13 filings, Versant Venture Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 148,831 shares valued at US$8.2M. Notable position changes include a 70% trim in Q3 2025 (shares fell 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 498.56K $22.63M New
Q4 2023 498.56K $31.21M Hold
Q1 2024 498.56K $33.98M Hold
Q2 2024 498.56K $26.93M Hold
Q3 2024 498.56K $23.42M Hold
Q4 2024 498.56K $19.62M Hold
Q1 2025 498.56K $16.97M Hold
Q2 2025 498.56K $24.25M Hold
Q3 2025 148.83K $9.65M Reduce
Q4 2025 148.83K $7.80M Hold
Q1 2026 148.83K $7.08M Hold
Q2 2026 148.83K $8.12M Hold
Q3 2026 148.83K $8.23M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRSP and 13F data

CRSP (CRISPR THERAPEUTICS AG) is a Health Care company. 30 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$556.3M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$144.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRSP

All CRSP fund holders →

FAQ

How long has Versant Venture Management, LLC held CRSP?

Versant Venture Management, LLC has disclosed CRSP holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Versant Venture Management, LLC's current position in CRSP?

As of Q3 2026, Versant Venture Management, LLC holds 148.83K shares of CRSP (CRISPR THERAPEUTICS AG), valued at $8.23M, representing 7.55% of its reported portfolio and ranking #6.

Has Versant Venture Management, LLC been buying or selling CRSP?

In the latest 13F filing (Q3 2026), Versant Venture Management, LLC held unchanged its position in CRSP. The position peaked in Q1 2024 at 498.56K shares.

Which other funds hold CRSP?

Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.